Literature DB >> 27638329

Prevalence of alcohol consumption during pregnancy and Fetal Alcohol Spectrum Disorders among the general and Aboriginal populations in Canada and the United States.

Svetlana Popova1, Shannon Lange2, Charlotte Probst3, Nino Parunashvili4, Jürgen Rehm5.   

Abstract

Prenatal alcohol exposure may cause a number of health complications for the mother and developing fetus, including Fetal Alcohol Spectrum Disorders (FASD). This study aimed to estimate the pooled prevalence of i) alcohol use (any amount) and binge drinking (4 or more standard drinks on a single occasion) during pregnancy, and ii) Fetal Alcohol Syndrome (FAS) and FASD among the general and Aboriginal populations in Canada and the United States, based on the available literature. Comprehensive systematic literature searches and meta-analyses, assuming a random-effects model, were conducted. It was revealed that about 10% and 15% of pregnant women in the general population consume alcohol in Canada and the United States, respectively, and that about 3% of women engage in binge drinking during pregnancy in both countries. However, the prevalence of alcohol use during pregnancy in the Aboriginal populations of the United States and Canada were found to be approximately 3-4 times higher, respectively, compared to the general population. Even more alarmingly, it was estimated that approximately one in five women in the Aboriginal populations in both countries engage in binge drinking during pregnancy. Further, among the general population of Canada, the pooled prevalence was estimated to be about 1 per 1000 for FAS and 5 per 1000 for FASD. However, compared to the general population, the prevalence of FAS and FASD among the Aboriginal population in Canada was estimated to be 38 times and 16 times higher, respectively. With respect to the United States, the pooled prevalence of FAS and FASD was estimated to be about 2 per 1000 and 15 per 1,000, respectively, among the general population, and 4 per 1000 and 10 per 1,000, respectively, among the Aboriginal population. The FAS and FASD pooled prevalence estimates presented here should be used with caution due to the limited number of existing studies and their methodological limitations. Based on the results of the current study, it is evident that there is an urgent need for implementing more effective national prevention and surveillance strategies to monitor and lower the prevalence of alcohol consumption during pregnancy and FASD.
Copyright © 2016 The Authors. Published by Elsevier Masson SAS.. All rights reserved.

Entities:  

Keywords:  Fetal alcohol spectrum disorders; Fetal alcohol syndrome; North America; Prenatal alcohol exposure; Prevalence

Mesh:

Substances:

Year:  2016        PMID: 27638329     DOI: 10.1016/j.ejmg.2016.09.010

Source DB:  PubMed          Journal:  Eur J Med Genet        ISSN: 1769-7212            Impact factor:   2.708


  38 in total

1.  Prenatal and postnatal alcohol exposure increases vulnerability to cocaine addiction in adult mice.

Authors:  Lídia Cantacorps; Sandra Montagud-Romero; Miguel Ángel Luján; Olga Valverde
Journal:  Br J Pharmacol       Date:  2020-01-23       Impact factor: 8.739

2.  The Standardization of Diagnostic Criteria for Fetal Alcohol Spectrum Disorder (FASD): Implications for Research, Clinical Practice and Population Health.

Authors:  Jasmine M Brown; Roger Bland; Egon Jonsson; Andrew J Greenshaw
Journal:  Can J Psychiatry       Date:  2018-05-22       Impact factor: 4.356

3.  The Psychiatric Morbidity of Women Who Give Birth to Children with Fetal Alcohol Spectrum Disorder (FASD): Results of the Manitoba Mothers and FASD Study.

Authors:  Deepa Singal; Marni Brownell; Dan Chateau; Ana Hanlon-Dearman; Sally Longstaffe; Leslie L Roos
Journal:  Can J Psychiatry       Date:  2017-05-26       Impact factor: 4.356

4.  State Policies Targeting Alcohol Use during Pregnancy and Alcohol Use among Pregnant Women 1985-2016: Evidence from the Behavioral Risk Factor Surveillance System.

Authors:  Sarah C M Roberts; Amy A Mericle; Meenakshi S Subbaraman; Sue Thomas; Ryan D Treffers; Kevin L Delucchi; William C Kerr
Journal:  Womens Health Issues       Date:  2019-03-12

5.  Activity-dependent Signaling and Epigenetic Abnormalities in Mice Exposed to Postnatal Ethanol.

Authors:  Shivakumar Subbanna; Vikram Joshi; Balapal S Basavarajappa
Journal:  Neuroscience       Date:  2018-07-20       Impact factor: 3.590

6.  Self-regulation and emotional reactivity in infants with prenatal exposure to opioids and alcohol.

Authors:  Kathryn G Beauchamp; Jean Lowe; Ronald M Schrader; Shikhar Shrestha; Crystal Aragón; Natalia Moss; Julia M Stephen; Ludmila N Bakhireva
Journal:  Early Hum Dev       Date:  2020-07-02       Impact factor: 2.079

7.  Prenatal alcohol exposure enhances the susceptibility to NMDA-induced generalized tonic-clonic seizures in developing rats.

Authors:  Sue J Cho; David M Lovinger; Prosper N'Gouemo
Journal:  CNS Neurosci Ther       Date:  2017-10       Impact factor: 5.243

8.  Impaired Bidirectional Synaptic Plasticity in Juvenile Offspring Following Prenatal Ethanol Exposure.

Authors:  Christine J Fontaine; Cristina Pinar; Waisley Yang; Angela F Pang; Konrad E Suesser; James S J Choi; Brian R Christie
Journal:  Alcohol Clin Exp Res       Date:  2019-08-26       Impact factor: 3.455

Review 9.  Maternal iron nutriture as a critical modulator of fetal alcohol spectrum disorder risk in alcohol-exposed pregnancies.

Authors:  Kaylee K Helfrich; Nipun Saini; Pamela J Kling; Susan M Smith
Journal:  Biochem Cell Biol       Date:  2017-10-10       Impact factor: 3.626

10.  Nurse home visiting and prenatal substance use in a socioeconomically disadvantaged population in British Columbia: analysis of prenatal secondary outcomes in an ongoing randomized controlled trial.

Authors:  Nicole L A Catherine; Michael Boyle; Yufei Zheng; Lawrence McCandless; Hui Xie; Rosemary Lever; Debbie Sheehan; Andrea Gonzalez; Susan M Jack; Amiram Gafni; Lil Tonmyr; Lenora Marcellus; Colleen Varcoe; Ange Cullen; Kathleen Hjertaas; Caitlin Riebe; Nikolina Rikert; Ashvini Sunthoram; Ronald Barr; Harriet MacMillan; Charlotte Waddell
Journal:  CMAJ Open       Date:  2020-10-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.